MIRA Pharmaceuticals, Inc. (MIRA) stock
MIRANasdaqPharmaceutical Preparations
$0.29−0.08 (-20.99%)
Close on Nov 20, 2026Market cap $12.23MP/E –Yield –
MIRA Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
MIRA Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$4.64M. For fiscal 2025 it was -$4.66M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$4.66M | – |
| FY2024 | Dec 31, 2024 | -$5.56M | – |
| FY2023 | Dec 31, 2023 | -$4.53M | – |
| FY2022 | Dec 31, 2022 | -$5.60M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.21M | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.20M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.14M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.10M | – |
| Q2 FY2025 | Jun 30, 2025 | -$799.65K | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.63M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.81M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.84M | – |
| Q2 FY2024 | Jun 30, 2024 | -$863.93K | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.05M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.04M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.76M | – |
| Q2 FY2023 | Jun 30, 2023 | -$660.81K | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.08M | – |
| Q4 FY2022 | Dec 31, 2022 | -$975.44K | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.31M | – |
See a number that looks wrong?